Corcept Therapeutics
CORT
#3439
Rank
A$6.03 B
Marketcap
A$57.25
Share price
-10.63%
Change (1 day)
-47.43%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): A$0.10 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.74 Billion. In 2024 the company made an earning of A$0.19 Billion, an increase over its 2023 earnings that were of A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.10 B-48.09%
2024 A$0.19 B27.66%
2023 A$0.15 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.17 B-2.91%
2020 A$0.18 B14.87%
2019 A$0.16 B24.71%
2018 A$0.12 B69.32%
2017 A$75.89 M419.26%
2016 A$14.61 M-395.64%
2015 -A$4.95 Million-87.53%
2014 -A$39.67 Million-33.44%
2013 -A$59.59 Million
2011 -A$46.43 Million17.84%
2010 -A$39.41 Million35.5%
2009 -A$29.08 Million2.84%
2008 -A$28.28 Million60.81%
2007 -A$17.59 Million-52.14%
2006 -A$36.74 Million20.91%
2005 -A$30.39 Million31.87%
2004 -A$23.05 Million60.54%
2003 -A$14.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.57 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$17.01 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.31 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.15 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.53 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$44.2 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$39.41 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.97 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA